Real-world implementation of dolutegravir plus lamivudine in people living with HIV in Southwest China.

Xiaoyan YangYanhua FuXiaoxin XieLin GanChunli SongYebing SongJun LiHai Long

Published in: Expert review of anti-infective therapy (2022)

Virologic suppression may be achieved with DTG+3TC, in ART-naïve patients with a high VL, and in ART-experienced patients with residual viremia. This study also demonstrated a low prevalence of drug-related side effects.

Keyphrases

antiretroviral therapy
hiv infected
hiv infected patients
healthcare
primary care
risk factors
quality improvement
emergency department